BSX
Income statement / Annual
Last year (2023), Boston Scientific Corporation's total revenue was $14.24 B,
an increase of 12.29% from the previous year.
In 2023, Boston Scientific Corporation's net income was $1.59 B.
See Boston Scientific Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$14.24 B
|
$12.68 B
|
$11.89 B
|
$9.91 B
|
$10.74 B
|
$9.82 B
|
$9.05 B
|
$8.39 B
|
$7.48 B
|
$7.38 B
|
| Cost of Revenue |
$4.35 B |
$4.00 B |
$3.76 B |
$3.51 B |
$3.18 B |
$2.88 B |
$2.66 B |
$2.50 B |
$2.24 B |
$2.32 B |
| Gross Profit |
$9.90 B |
$8.68 B |
$8.13 B |
$6.40 B |
$7.55 B |
$6.94 B |
$6.39 B |
$5.88 B |
$5.23 B |
$5.06 B |
| Gross Profit Ratio |
0.69 |
0.68 |
0.68 |
0.65 |
0.7 |
0.71 |
0.71 |
0.7 |
0.7 |
0.69 |
| Research and Development
Expenses |
$1.41 B
|
$1.32 B
|
$1.20 B
|
$1.14 B
|
$1.17 B
|
$1.11 B
|
$997.00 M
|
$920.00 M
|
$876.00 M
|
$817.00 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.57 B
|
$3.29 B
|
$3.10 B
|
$2.87 B
|
$2.90 B
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.19 B
|
$4.52 B
|
$4.36 B
|
$3.79 B
|
$3.94 B
|
$3.57 B
|
$3.29 B
|
$3.10 B
|
$2.87 B
|
$2.90 B
|
| Other Expenses |
-$14.00 M |
$803.00 M |
$741.00 M |
$789.00 M |
$699.00 M |
$156.00 M |
-$124.00 M |
-$37.00 M |
-$39.00 M |
$8.00 M |
| Operating Expenses |
$7.48 B |
$6.65 B |
$6.30 B |
$5.72 B |
$5.81 B |
$5.28 B |
$4.86 B |
$4.56 B |
$4.24 B |
$4.16 B |
| Cost And Expenses |
$11.82 B |
$10.65 B |
$10.06 B |
$9.23 B |
$9.00 B |
$8.16 B |
$7.52 B |
$7.07 B |
$6.49 B |
$6.48 B |
| Interest Income |
$22.00 M |
$10.00 M |
$4.00 M |
$3.00 M |
$30.00 M |
$3.00 M |
$5.00 M |
$5.00 M |
$5.00 M |
$5.00 M |
| Interest Expense |
$265.00 M |
$470.00 M |
$341.00 M |
$361.00 M |
$473.00 M |
$241.00 M |
$229.00 M |
$233.00 M |
$284.00 M |
$216.00 M |
| Depreciation &
Amortization |
$1.20 B
|
$1.14 B
|
$1.09 B
|
$1.12 B
|
$1.01 B
|
$894.00 M
|
$844.00 M
|
$815.00 M
|
$495.00 M
|
$438.00 M
|
| EBITDA |
$3.62 B
|
$2.80 B
|
$2.78 B
|
$1.83 B
|
$2.08 B
|
$2.42 B
|
$1.97 B
|
$1.83 B
|
$1.45 B
|
$1.35 B
|
| EBITDA Ratio |
0.25 |
0.22 |
0.23 |
0.18 |
0.19 |
0.25 |
0.22 |
0.22 |
0.19 |
0.18 |
| Operating Income Ratio
|
0.16
|
0.13
|
0.17
|
0.11
|
0.14
|
0.15
|
0.14
|
0.05
|
-0.04
|
0.04
|
| Total Other
Income/Expenses Net |
-$188.00 M
|
-$508.00 M
|
-$967.00 M
|
-$1.18 B
|
-$831.00 M
|
$3.00 M
|
-$370.00 M
|
-$909.00 M
|
-$1.36 B
|
-$595.00 M
|
| Income Before Tax |
$1.99 B |
$1.14 B |
$1.08 B |
-$138.00 M |
$687.00 M |
$1.42 B |
$933.00 M |
$177.00 M |
-$650.00 M |
$91.00 M |
| Income Before Tax Ratio
|
0.14
|
0.09
|
0.09
|
-0.01
|
0.06
|
0.14
|
0.1
|
0.02
|
-0.09
|
0.01
|
| Income Tax Expense |
$393.00 M |
$443.00 M |
$36.00 M |
$2.00 M |
-$4.01 B |
-$249.00 M |
$828.00 M |
-$170.00 M |
-$411.00 M |
-$176.00 M |
| Net Income |
$1.59 B |
$698.00 M |
$1.04 B |
-$140.00 M |
$4.70 B |
$1.67 B |
$104.00 M |
$347.00 M |
-$239.00 M |
$267.00 M |
| Net Income Ratio |
0.11 |
0.06 |
0.09 |
-0.01 |
0.44 |
0.17 |
0.01 |
0.04 |
-0.03 |
0.04 |
| EPS |
1.08 |
0.45 |
0.69 |
-0.0988 |
3.38 |
1.21 |
0.0759 |
0.26 |
-0.18 |
0.2 |
| EPS Diluted |
1.07 |
0.45 |
0.69 |
-0.0988 |
3.33 |
1.19 |
0.0747 |
0.25 |
-0.18 |
0.2 |
| Weighted Average Shares
Out |
$1.45 B
|
$1.43 B
|
$1.42 B
|
$1.42 B
|
$1.39 B
|
$1.38 B
|
$1.37 B
|
$1.36 B
|
$1.33 B
|
$1.32 B
|
| Weighted Average Shares
Out Diluted |
$1.46 B
|
$1.44 B
|
$1.43 B
|
$1.42 B
|
$1.41 B
|
$1.40 B
|
$1.39 B
|
$1.38 B
|
$1.34 B
|
$1.35 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
